Already have your IDs?

Thursday, September 8, 2022

14:30 - 15:43 :  EYRC Oral communications


14:30 -14:39Molecular mechanisms of cavernous sinus invasion by pituitary adenomas: in vitro studies and in vivo investigations in a rat model of invasive pituitary tumorigenesis obtained by stereotactic pituitary GC cells injectionFanny CHASSELOUP
14:39 -14:48Circulating microRNAs as predictors for dopamine agonists in hyperprolactinemic patients with pituitary adenomaJae Won WONG
14:48 -14:57Effect of a novel somatostatin receptor 5/3 agonist, HTL0030310, on human GH- and ACTH-secreting pituitary adenomas in vitroDaniela REGAZZO
14:57 -15:06Xq26.3 duplications in X-linked acrogigantism (X-LAG) disrupt a topologically associating domain (TAD) and rewire GPR101-enhancer interactionsMartin FRANKE
15:06 -15:15Morphological and molecular evidence of macroautophagy in pituitary tumorsLaura CECENARRO
15:15 -15:24New provocation test using MDMA (‘Ecstasy') demonstrates Oxytocin deficiency in patients with central diabetes insipidusCihan ATILA
15:24 -15:33Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross-sectional UK Biobank studyMerel VAN DER MEULEN
15:33 -15:43CRN04894: an oral, nonpeptide ACTH (MC2) receptor antagonist decreaseds basal and stimulated cortisol secretion in healthy volunteersPeter TRAINER